US FDA gives OK to Impax's generic Doryx
This article was originally published in Scrip
The US FDA has granted final approval for Impax Laboratories' generic version of Warner Chilcott's antibiotic Doryx (doxycycline hyclate delayed-release) 75mg and 100mg tablets.
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.